Market capitalization | AUD12.63b |
Enterprise Value | AUD16.19b |
PER (TTM) P/E ratio | 24.52 |
EV/FCF (TTM) EV/FCF | 23.33 |
EV/Sales (TTM) EV/Sales | 1.97 |
P/S ratio (TTM) P/S ratio | 1.54 |
P/B ratio (TTM) P/B ratio | 1.63 |
Dividend yield | 3.95% |
Last dividend (FY23) | AUD1.04 |
As a free StocksGuide basic user, you can view the scores for all 6,953 shares worldwide.
17 Analysts have issued a Sonic Healthcare forecast:
17 Analysts have issued a Sonic Healthcare forecast:
Dec '23 |
+/-
%
|
||
Turnover | 8,211 8,211 |
4%
4%
|
|
Gross income | 2,034 2,034 |
25%
25%
|
|
EBITDA | 1,365 1,365 |
36%
36%
|
EBIT (operating result) EBIT | 624 624 |
56%
56%
|
Net profit | 505 505 |
50%
50%
|
Figures in millions AUD.
If you wish, you can receive an e-mail every morning in time for breakfast containing all the stock news relevant to you.
Sonic Healthcare Ltd. engages in the provision of medical diagnostics services. It operates through the following segments: Laboratory, Radiology, and Other. The Laboratory segment offers pathology and clinical services in Australia, New Zealand, the United Kingdom, the United States of America, Germany, Switzerland, Belgium, and Ireland. The Radiology segment includes diagnostic imaging services in Australia. The Other segment covers the corporate office function, medical center operations and occupation health services, and other minor operations. The company was founded on September 25, 1934 and is headquartered in Sydney, Australia.
Head office | Australia |
CEO | Colin Goldschmidt |
Employees | 41,000 |
Founded | 1934 |
Website | www.sonichealthcare.com |
StocksGuide is the tool for easily finding, analyzing and monitoring shares. Learn from successful investors and make well-founded investment decisions. We make you a self-determined investor.